Mutations in TβRII, abrogating TGF-β signaling, occur late in the adenoma to carcinoma sequence [113] and have been detected in about 30% of all CRCs [114], and in more than 80% of CRCs presenting microsatellite instability (MSI-H) [115,116]. Here, TGFB1 is linked to adenoma.